< Back to latest news & events

News

Upcoming Webinar: Top 10 Alternative Protein Challenges

March 2024

EVENT DATE: 27th March 2024

EVENT TIME: 3.00 pm (GMT)

Partner and Patent Attorney Kerry Rees will be a guest speaker at Protein Production Technology’s upcoming webinar on Wednesday 27th March 2024.

This is a free-to-attend webinar, where attendees will have the opportunity to hear from industry experts as well as interact through Q&A sessions.

Discover complexities in developing plant-based, cell-based, and cultured proteins, from taste and texture optimisation to scalability and cost-effectiveness. The panel of experts will highlight cutting-edge technologies like genetic engineering and advanced bioprocessing that drive alt-protein innovation.

Click the link below to reserve your spot for the Top 10 Challenges in Alt-Protein Development webinar.

RESERVE YOUR SPOT

Latest updates

Polymorphs: Clearing the Inventive Step Hurdle at the European Patent Office (EPO)

Polymorphic forms of active pharmaceutical ingredients (APIs) can represent commercially valuable compound subject matter and can be critical to providing necessary drug product characteristics and performance. However, patenting polymorphs is …

Read article

IQPC Global US Exchange

HGF are proud ‘Silver Plus’ sponsors of the IQPC Global US Exchange, at the Austin Marriot South, Texas. The IQPC Global US Exchange will be held at the Austin Marriot …

Read article

Update on the Precision Breeding Act 2023: details emerge of the new simplified regulatory pathway for gene edited plant and animal derived food and feed products

The Genetic Technology (Precision Breeding) Act 2023 could come into force as early as spring 2025. It empowers the Food Standards Agency (FSA) to create a new simplified regulatory pathway …

Read article

Court of Appeal Decision Upholds Invalidity of Patent Due to Amendment Identifying Embodiment as Outside the Scope of the Claims

In a case that highlights the challenges arising due to post-grant amendments, and in particular interpretation of the claims in view of the description, the Court of Appeal in Ensygnia …

Read article

UPC Court of Appeal clarifies approach for interpreting claims with “obvious” errors

Alexion Pharmaceuticals, Inc. v Samsung Bioepis NL B.V. [UPC_CoA_402/2024] –Court of Appeal of the UPC (Grabinski, Blok, Gougé, Enderlin, Hedberg) – 20 December 2024 Alexion Pharmaceuticals, Inc. v Amgen Technology …

Read article

IP Ingredients: Winter Case Law Review 2024

As the nights draw in and the frenzy to finish everything off before the holiday season reaches its peak, it’s time to take a break, grab your favourite hot beverage …

Read article
See all updates